1.Development and validation for the determination of total flavonoids and luteolin from Pteris multifida Poir
Mengwei LI ; Yuemei MA ; Aoxue LIU ; Hao WANG ; Xinjing CHEN ; Yang LIU
International Journal of Traditional Chinese Medicine 2017;39(7):617-621
Objective To determine the content of total flavonoids and luteolin from Pteris multifida Poir. Methods The content of total flavonoids was determined by gradient elution of macroporous resin D101 and ultraviolet spectrophotometry. The content of luteolin was determined by HPLC. The analysis was performed on a RP-C18 column(4.6 mm×250 mm, 5 μm) with aceconitrile-0.2% phosphoric acid (35:65) as the mobile phase at a flow rate of 1.0 ml/min, and 30 ℃ temperature. Results The detection of wave length was set at 349 nm. The content of luteolin was 0.015%, 0.019%, 0.016%, and the content of total flavonoids was 0.015%, 0.019%, 0.016%, respectively. Conclusions The method is suitable for the determination of flavonoids componets from Pteris multifida Poir.
2.Development and reliability and validity of the Fear of Disease Progression Scale for Patients with Acute Myocardial Infarction
Aoxue LI ; Xiaobo LI ; Aoshuang LI ; Jun LIU ; Jiejie SUN
Chinese Journal of Modern Nursing 2021;27(13):1710-1715
Objective:To develop the Fear of Disease Progression Scale for Patients with Acute Myocardial Infarction, and test its reliability and validity.Methods:The first draft of the scale was formed through literature review, qualitative interviews, and Delphi expert consultations. From March to July 2020, convenience sampling method was adopted to conduct a formal survey of 200 patients with acute myocardial infarction admitted to the Department of Cardiology in three ClassⅢ Grade A hospitals in Jiangsu Province. The formal scale was formed through the project analysis and exploratory factor analysis, and its reliability and validity were determined. 200 questionnaires were distributed, and 178 valid questionnaires were recovered, with a valid recovery rate of 89.00%.Results:The final scale contained 17 items, and exploratory factor analysis extracted 3 common factors, and the cumulative contribution rate of variance was 62.671%. The item-level content validity index ( I- CVI) was from 0.83 to 1.00, the scale-level content validity index ( S- CVI) was 0.82, and the average S- CVI was 0.97. The Cronbach's α coefficient of the total scale was 0.892, the half-reliability was 0.764, and the test-retest reliability was 0.964. Conclusions:The developed Fear of Disease Progression Scale for Patients with Acute Myocardial Infarction has good reliability and validity, which can be used to assess the current status of fear of disease progression in patients with acute myocardial infarction.
3.Simultaneous determination of isoquercetin and astragalin in Moringa oleifera leaves prescription-a prescription for treatment of constipation by HPLC
Aoxue LIU ; Wenhong GU ; Mengwei LI ; Xinjing CHEN ; Jun HE ; Xingfen LONG ; Yang LIU
International Journal of Traditional Chinese Medicine 2018;40(2):153-156
Objective To establish an HPLC method for simultaneous determination of Isoquercitrin and astragalin in Moringa oleifera leaves prescription. Methods By using HPLC method with Cosmosil-C18 column (4.6 mm × 250 mm, 5 μm) and the column temperature was 40 degrees Celsius, the mobile phase contains a 0.1%phosphoric acid in water(A) and acetonitrile(B), the detection wavelength was set at 350nm by UV detector and the flow rate was 1.3 ml/min. Results The Isoquercitrin and astragalin was better separated in 30 minutes, and Isoquercitrin had a good linear correlation at the range of 0.24-4.73 μg, while astragalin was 0.11-2.19 μg, the average spiked recoveries of isoquercetin and astragalin were 99.09% (RSD=0.60%) and 99.08% (RSD=1.37%), respectively. Conclusions The proposed method is simple,accurate,and repeatable and can be used for quality control as well as a powerful tool to evaluate the processing of Moringa oleifera leaves. It can provide the reference basis and data support for the determination of content of Moringa oleifera health products.
4.Current status and influencing factors of meaning of life in patients undergoing radical mastectomy
Jiejie SUN ; Xiaobo LI ; Aoxue LI ; Chengcheng CHEN ; Tingting ZHANG ; Yongping AO
Chinese Journal of Modern Nursing 2020;26(34):4756-4762
Objective:To explore the status quo of meaning of life in patients undergoing radical mastectomy and analyze the influencing factors.Methods:The convenient sampling method was used to select 302 patients with breast cancer who were treated in 2 Class Ⅲ Grade A hospitals in Zhenjiang from June 2019 to February 2020 as research objects. The general data questionnaire, Chinese version of Meaning in Life Questionnaire (C-MLQ) , Health-related Hardiness Scale (HRHS) and Cognitive Reassessment Strategy Scale were used to investigate them.Results:A total of 315 questionnaires were issued and 302 valid questionnaires were collected.The total score of C-MLQ of 302 patients undergoing radical mastectomy was (31.65±6.71) , the total score of HRHS was (92.59±5.68) and the total score of Cognitive Reassessment Strategy Scale was (16.23±5.04) .The results of multiple linear regression analysis showed that cognitive reassessment, postoperative time, health-related hardiness and its control dimension, family monthly income, gender, radiotherapy and chemotherapy were the influencing factors of meaning of life in patients undergoing radical mastectomy ( P<0.05) , which explained 85.8% of the variation in meaning of life. Conclusions:The meaning of life of patients undergoing radical mastectomy is at a medium low level. Clinical medical staff should take effective intervention measures to improve cognitive reassessment ability of patients, so that they can have correct cognition of the disease. They should also encourage them to face the disease actively and bravely and strengthen their own health-related hardinessin order to improve the meaning of life.
5.Efficacy of postmastectomy radiotherapy for HER2-positive T 1-2N 1M 0 breast cancer
Yongchun ZHOU ; Yaoguo YANG ; Nan SUN ; Lingxiao XIE ; Xianglu SUN ; Aoxue LI ; Qiong WU ; Lei ZHANG ; Hao JIANG
Chinese Journal of Radiological Medicine and Protection 2023;43(9):676-681
Objective:To investigate the efficacy of postmastectomy radiotherapy (PMRT) for human epidermal growth factor receptor 2 (HER2)-positive T 1-2N 1M 0 breast cancer in the context of HER2-targeted therapy. Methods:This study collected the clinical data of 105 female patients with HER2-positive T 1-2N 1M 0 breast cancer who underwent modified radical mastectomy in the First Affiliated Hospital of Bengbu Medical College from January 2013 to December 2019. Then, the clinical outcomes of these patients were observed, and the prognostic factors and the efficacy of PMRT were analyzed. Results:The median follow-up time was 50 months (ranging from 14 to 107 months), and the 5-year overall survival (OS), local-regional recurrence-free survival(LRFS), and disease-free survival (DFS) were 81.6%, 91.9%, and 76.2%, respectively. The multivariate analysis indicated that independent prognostic factors for OS and DFS include the age, pathologic grade, and tumor size; the independent risk factors for LRFS include positive lymph node ratio (LNR) and hormone receptor (HR) status; and the independent prognostic factor for DFS was PMRT (HR: 2.85, 95% CI: 1.10-8.80, P < 0.05). The subgroup analysis suggested that PMRT significantly improved the OS of various high-risk subgroups ( χ2=4.01-9.18, P < 0.05). However, the further stratified analysis indicated that PMRT only increased the OS of the patients who did not receive HER2-targeted therapy in various high-risk subgroups ( χ2=4.50-6.70, P < 0.05), while there was no statistical difference before and after PMRT for the individuals who received targeted treatment ( P > 0.05). Conclusions:PMRT is an independent prognostic factor for the DFS of patients with HER2-positive T 1-2N 1M 0 breast cancer who underwent modified radical mastectomy. PMRT can improve the OS of high-risk patients with ages < 45 years old, pathologic grade Ⅲ, tumor diameter ≥ 3 cm, LNR > 10%, and HR (-) who received no HER2-targeted therapy. However, the efficacy may be compromised to some extent in the context of the application of HER2-targeted therapy.
6.Clinical and genetic analysis of a patient with Loeys-Dietz syndrome due to variant of TGFBR2 gene.
Yueli WANG ; Zhihua KONG ; Long WAN ; Aoxue WANG ; Xiaoyan LI
Chinese Journal of Medical Genetics 2023;40(12):1531-1535
OBJECTIVE:
To explore the genetic basis of a patient with clinically suspected Loeys-Dietz syndrome (LDS).
METHODS:
A child who had presented at Beijing Anzhen Hospital in September 2018 was selected as the study subject. Clinical data and family history of the patient were collected, along with peripheral blood samples of the proband and his parents. Whole exome sequencing (WES) was carried out through next-generation sequencing.
RESULTS:
Candidate variants were searched through bioinformatic analysis focusing on genes associated with hereditary aortic aneurysms. Candidate variant was verified by Sanger sequencing. The patient was found to have cardiovascular abnormalities including early-onset aortic dilatation and coarctation, and LDS syndrome was suspected. WES revealed that he has harbored a heterozygous c.1526G>T missense variant of the TGFBR2 gene. The same variant was not found in either parent and was predicted as likely pathogenic (PM1+PM2_Supporting+ PM6+PP3+PP4) based on the guidelines from the American College for Medical Genetics and Genomics (ACMG).
CONCLUSION
The TGFBR2 c.1526G>T variant probably underlay the LDS in this patient and was unreported previously in China. Above finding has enriched the mutational spectrum of the TGFBR2 gene associated with the LDS and provided a basis for the genetic counseling for the patient.
Child
;
Humans
;
Male
;
China
;
Computational Biology
;
Family
;
Loeys-Dietz Syndrome/genetics*
;
Mutation
;
Receptor, Transforming Growth Factor-beta Type II/genetics*
7.Effect of obesity factor on myocardial ischemia-reperfusion injury in mice and role of TRPA1 expression
Min WANG ; Shuai QIN ; Aoxue LI ; Yun WU
Chinese Journal of Anesthesiology 2024;44(4):471-475
Objective:To evaluate the effect of obesity factor on myocardial ischemia-reperfusion injury and the role of transient receptor potential ankyrin 1 (TRPA1) expression in mice.Methods:Twenty-four SPF healthy male C57BL/6J mice, aged 6-7 weeks, weighing 18-21 g, were divided into 2 groups ( n=12 each) using a random number table method: common diet group (CD group) and high fat diet group (HFD group). CD group was fed a common diet and HFD group was fed a high-fat diet supplied with 60% fat for 12 weeks, and the body weight of mice was recorded every week. The mice in CD group were then divided into 2 groups ( n=6 each) using a random number table method: CD+ solvent group (CD+ C group) and CD+ TRPA1 agonist allyl isothiocyanate (AITC) group (CD+ A group). The mice in group HFD were divided into 2 groups ( n=6 each) using a random number table method: HFD+ solvent group (HFD+ C group) and HFD+ AITC group (HFD+ A group). At 13th week, AITC 25 mg·kg -1·d -1 was intragastrically administered based on the original diet in CD+ A group and HFD+ A group, and the equal volume of solvent was given in CD+ C and HFD+ C groups. At 14th week, myocardial I/R injury was established by occlusion of the left coronary artery for 30 min followed by 120-min reperfusion. The body weight, epididymal fat, mesenteric fat and perirenal fat were recorded, and the levels of LDH, triglyceride and cholesterol in serum were determined. The percentage of myocardial infarct size was calculated. The expression of TRPA1, Bax and Bcl-2 was detected by Western blot, and the ratio of Bax/Bcl-2 was calculated. Results:Compared with CD+ C group, the expression of TRPA1 in myocardial tissues was significantly up-regulated ( P<0.05), and no significant differences were found in the other parameters in CD+ A group ( P>0.05), and the concentrations of serum triglyceride and cholesterol, body weight, weight of epididymal fat, mesenteric fat, perirenal fat and percentage of myocardial infarct size were significantly increased, the expression of TRPA1 in myocardial tissues was down-regulated, and the concentration of LDH and ratio of Bax/Bcl-2 were increased in HFD+ C group ( P<0.05). Compared with HFD+ C group, the concentrations of serum triglyceride and cholesterol, body weight, weight of epididymal fat, mesenteric fat, perirenal fat and percentage of myocardial infarct size were significantly decreased, the expression of TRPA1 in myocardial tissues was up-regulated, and the concentration of LDH and ratio of Bax/Bcl-2 were decreased in HFD+ A group ( P<0.05). Conclusions:Obesity can aggravate myocardial ischemia-reperfusion injury in mice, and the down-regulated myocardial TRPA1 expression is involved in this process.